Developmental Endocrinology Unit, Laboratory of Hormones and Molecular Genetics LIM/42, University of Sao Paulo, Sao Paulo, Brazil.
Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Lancet Diabetes Endocrinol. 2023 Aug;11(8):545-554. doi: 10.1016/S2213-8587(23)00131-6. Epub 2023 Jun 26.
Identification of genetic causes of central precocious puberty have revealed epigenetic mechanisms as regulators of human pubertal timing. MECP2, an X-linked gene, encodes a chromatin-associated protein with a role in gene transcription. MECP2 loss-of-function mutations usually cause Rett syndrome, a severe neurodevelopmental disorder. Early pubertal development has been shown in several patients with Rett syndrome. The aim of this study was to explore whether MECP2 variants are associated with an idiopathic central precocious puberty phenotype.
In this translational cohort study, participants were recruited from seven tertiary centres from five countries (Brazil, Spain, France, the USA, and the UK). Patients with idiopathic central precocious puberty were investigated for rare potentially damaging variants in the MECP2 gene, to assess whether MECP2 might contribute to the cause of central precocious puberty. Inclusion criteria were the development of progressive pubertal signs (Tanner stage 2) before the age of 8 years in girls and 9 years in boys and basal or GnRH-stimulated LH pubertal concentrations. Exclusion criteria were the diagnosis of peripheral precocious puberty and the presence of any recognised cause of central precocious puberty (CNS lesions, known monogenic causes, genetic syndromes, or early exposure to sex steroids). All patients included were followed up at the outpatient clinics of participating academic centres. We used high-throughput sequencing in 133 patients and Sanger sequencing of MECP2 in an additional 271 patients. Hypothalamic expression of Mecp2 and colocalisation with GnRH neurons were determined in mice to show expression of Mecp2 in key nuclei related to pubertal timing regulation.
Between Jun 15, 2020, and Jun 15, 2022, 404 patients with idiopathic central precocious puberty (383 [95%] girls and 21 [5%] boys; 261 [65%] sporadic cases and 143 [35%] familial cases from 134 unrelated families) were enrolled and assessed. We identified three rare heterozygous likely damaging coding variants in MECP2 in five girls: a de novo missense variant (Arg97Cys) in two monozygotic twin sisters with central precocious puberty and microcephaly; a de novo missense variant (Ser176Arg) in one girl with sporadic central precocious puberty, obesity, and autism; and an insertion (Ala6_Ala8dup) in two unrelated girls with sporadic central precocious puberty. Additionally, we identified one rare heterozygous 3'UTR MECP2 insertion (36_37insT) in two unrelated girls with sporadic central precocious puberty. None of them manifested Rett syndrome. Mecp2 protein colocalised with GnRH expression in hypothalamic nuclei responsible for GnRH regulation in mice.
We identified rare MECP2 variants in girls with central precocious puberty, with or without mild neurodevelopmental abnormalities. MECP2 might have a role in the hypothalamic control of human pubertal timing, adding to the evidence of involvement of epigenetic and genetic mechanisms in this crucial biological process.
Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, and the Wellcome Trust.
中枢性性早熟的遗传病因鉴定揭示了表观遗传机制是人类青春期启动时间的调控因素。MECP2 是一个 X 连锁基因,编码一种与染色质相关的蛋白,在基因转录中起作用。MECP2 功能丧失突变通常导致雷特综合征,这是一种严重的神经发育障碍。已经在一些雷特综合征患者中观察到早期青春期发育。本研究旨在探讨 MECP2 变异是否与特发性中枢性性早熟表型有关。
在这项转化队列研究中,参与者来自五个国家(巴西、西班牙、法国、美国和英国)的七个三级中心招募。对特发性中枢性性早熟患者进行 MECP2 基因中潜在致病变异的罕见检测,以评估 MECP2 是否可能导致中枢性性早熟。纳入标准为女孩在 8 岁以下和男孩在 9 岁以下出现进行性青春期征象(Tanner 分期 2),基础或 GnRH 刺激 LH 青春期浓度。排除标准为外周性早熟的诊断和存在任何已知的中枢性性早熟原因(中枢神经系统病变、已知的单基因病因、遗传综合征或早期接触性激素)。所有纳入的患者均在参与学术中心的门诊接受随访。我们在 133 例患者中使用高通量测序,在另外 271 例患者中使用 MECP2 的 Sanger 测序。为了证明 Mecp2 在与青春期时间调节相关的关键核中表达,并与 GnRH 神经元共定位,我们在小鼠中检测了 Mecp2 的表达。
在 2020 年 6 月 15 日至 2022 年 6 月 15 日期间,共纳入并评估了 404 例特发性中枢性性早熟患者(383 例[95%]女孩和 21 例[5%]男孩;261 例[65%]散发性病例和 143 例[35%]家族性病例来自 134 个无关家庭)。我们在 5 名女孩中发现了 MECP2 中三个罕见的杂合性可能致病变异:两名中枢性性早熟和小头畸形的同卵双胞胎中存在新生错义变异(Arg97Cys);一名散发性中枢性性早熟、肥胖和自闭症的女孩中存在新生错义变异(Ser176Arg);两名散发性中枢性性早熟的女孩中存在两个不相关的插入(Ala6_Ala8dup)。此外,我们还在两名散发性中枢性性早熟的女孩中发现了 MECP2 罕见的 3'UTR 插入(36_37insT)。她们均未表现出雷特综合征。Mecp2 蛋白在负责 GnRH 调节的下丘脑核中与 GnRH 表达共定位,在小鼠中。
我们在中枢性性早熟女孩中发现了罕见的 MECP2 变异,这些女孩有或没有轻度神经发育异常。MECP2 可能在人类青春期启动的下丘脑控制中发挥作用,这增加了表观遗传和遗传机制在这一关键生物学过程中的作用的证据。
巴西圣保罗研究支持基金会、巴西国家科学技术发展理事会和惠康信托基金会。